News
Latest news related to non-animal research
-
13 May 2026Digital twins in drug development, Top 10 Organoid Companies, Inside preclinical NAMs innovation, Novel bioprinting method, and more
NEWS, REPORTS & POSITION STATEMENTS 1. How ever-expanding organoids from epithelial stem cells were developed A new publication in Cell Stem Cell describes the scientific journey of Prof Hans Clevers and his lab at Utrecht Institute, which began in immunology […]
Read more -
7 May 2026European Parliament strengthens ECHA’s role, Model-informed strategies for antibody-drug conjugates, Next generation OOC for bone cancer, NC3Rs: Antibody Champions, and more
NEWS, REPORTS & POSITION STATEMENTS 1. European Parliament strengthens ECHA’s role At its plenary session on Wednesday 29 April, European Parliament (EP) adopted its negotiating position regarding the reform of the European Chemicals Agency (ECHA) (526 votes in favour, 56 […]
Read more -
29 April 2026Effectiveness of VCGs in toxicology, Institutional biobanking, PARC training on in silico models, Mimetas Tumor – Vasculature-on-Chip, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Charles River highlights effectiveness of VCGs in toxicology Charles River Laboratories International has shared the results of a retrospective analysis showing that virtual control groups (VCGs) can preserve scientific integrity while reducing reliance on […]
Read more -
22 April 2026The Merck “3 Baskets” approach, Future Market Insights report on the OOC market, Anivance AI selected by the FNIH NAMs pilot, OpenAI Foundation for Alzheimer, and more
NEWS, REPORTS & POSITION STATEMENTS 1. The Merck “3 Baskets” approach for creating roadmaps to phase out animal testing In ALTEX latest issue, Kerstin Kleinschmidt-Doerr et al. describe their Merck KGaA 3 Baskets (3B) strategy, introduced in 2021, to reduce […]
Read more -
16 April 2026ICH S7A revised after 25 Years, Harmonized definition for NAMs, OOC into space, Personalized models of Schizophrenia, and more
NEWS, REPORTS & POSITION STATEMENTS 1. ICH S7A revised after 25 Years: Why it matters for NAMs developers The International Council for Harmonisation (ICH) S7A guideline on safety pharmacology studies, finalized in 2000, has been pivotal in protecting clinical trial […]
Read more
